Drug Profile
TL 310
Alternative Names: TL-310Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Taxolog
- Class Antineoplastics; Taxanes
- Mechanism of Action Mitosis inhibitors; Tubulin modulators; Tubulin polymerisation promoters
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Solid tumours
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for phase-I development in Solid-tumours(Recurrent) in United Kingdom (PO)
- 06 Jul 2007 Phase-I clinical trials in Solid tumours in United Kingdom (PO)